Inventor · disambiguated record
Lan Thi Hoang Dang
Also filed as: DANG LAN THI HOANG
0 granted patents·8 pending applications·0 citations·filing 2021–2024
Files withALNYLAM PHARMACEUTICALS INC8
Top patents by PatentIndex Score
8 records- 0175US2025115911A1Snca-targeting sirna compositions for treating snca-associated diseaseALNYLAM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0274US2025059541A1Snca-targeting sirna compositions for treating snca-associated diseaseALNYLAM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0366US2024240182A1HUMAN CHROMOSOME 9 OPEN READING FRAME 72 (C9ORF72) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOFALNYLAM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0461US2024200077A1Stearoyl-coa desaturase 5 (scd5) irna agent compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0557US2024011032A1Snca irna compositions and methods of use thereof for treating or preventing snca-associated neurodegenerative diseasesALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0656US2025011778A1APP iRNA Compositions and Methods of Use Thereof for Treating or Preventing Diseases Characterized by Enlarged EndosomesALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0755US2024301426A1Leucine-rich repeat kinase 2 (lrrk2) irna agent compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0850US2023126233A1LEUCINE-RICH REPEAT KINASE 2 (LRRK2) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOFALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lan Thi Hoang Dang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →